Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

Chronic Kidney Disease IV: Nursing Management

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development and characterization of a standardized adipogenesis assay for testing metabolism disrupting chemicals using human bone marrow derived mesenchymal stem cells.

NAM journal·2026

Same author

GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation.

Diabetes, obesity & metabolism·2026

Same author

Heritable changes in chromatin contacts associated with transgenerational susceptibility to diet-induced insulin dysregulation and obesity.

Nature communications·2026

Same author

Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID-Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome. <i>Viruses</i> 2025, <i>17</i>, 619.

Viruses·2026

Same author

Thermogenic Differentiation of Human Adipocyte Precursors in Culture: A Systematic Review.

Cells·2025

Same author

A systematic review of exposure to endocrine disruptors and energy expenditure in mice.

Environmental health : a global access science source·2025

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Thyroid hormone action in chronic kidney disease.

Angélica Amorim Amato¹, Guilherme Martins Santos, Francisco de Assis Rocha Neves

¹Molecular Pharmacology Laboratory, Faculty of Health Sciences, University of Brasília, Brasília, Brazil.

Current Opinion in Endocrinology, Diabetes, and Obesity

|September 5, 2008

Summary

Chronic kidney disease (CKD) disrupts thyroid hormone regulation. Uremic toxins interfere with thyroid hormone transport and action, potentially causing resistance in some tissues, though the full impact remains unclear.

Related Experiment Videos

Last Updated: Jul 2, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Area of Science:

Endocrinology
Nephrology

Background:

Chronic kidney disease (CKD) is associated with significant alterations in thyroid hormone physiology.
These changes affect multiple aspects of thyroid hormone homeostasis.

Purpose of the Study:

To review the effects of uremia on thyroid hormone synthesis, metabolism, transport, and action.
To explore the mechanisms underlying thyroid hormone resistance in CKD.

Main Methods:

Literature review of studies investigating thyroid hormone abnormalities in CKD.
Analysis of the impact of uremic toxins on thyroid hormone pathways.

Main Results:

Uremic toxins interfere with thyroid hormone transport across cell membranes.
These toxins also affect thyroid hormone receptor activity, contributing to tissue resistance.
These mechanisms may explain observed thyroid hormone resistance in CKD patients.

Conclusions:

The exact pathogenesis of thyroid axis dysfunction in uremia is not fully understood.
The clinical significance of these abnormalities and the potential role of thyroid hormone therapy require further investigation.
Given the rising prevalence of CKD, understanding these metabolic consequences is crucial.